Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol Myers Squibb
Bristol Myers Squibb
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
M&A
R&D
AbbVie
AstraZeneca
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
BMS signs ADC development deal with Munich-based biotech worth more than $1B
Medical Marketing and Media
Thu, 04/20/23 - 12:00 pm
Bristol Myers Squibb
Tubulius
cancer
solid tumors
antibody-drug conjugate
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows
Fierce Pharma
Wed, 04/19/23 - 11:24 am
CAR-T
Bristol Myers Squibb
JNJ
Legend Biotech
AACR
Multiple Myeloma
Carvykti
Abecma
Foundation Medicine to collaborate with Bristol Myers Squibb on companion diagnostic for solid tumors
LabPulse
Tue, 04/11/23 - 07:25 pm
Bristol Myers Squibb
Foundation Medicine
diagnostics
FoundationOne
companion diagnostics
repotrectinib
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Mon, 04/3/23 - 03:33 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Bristol Myers Squibb Takes Off on Latest SpaceX Flight for Protein Crystallization Research
Xtalks
Sun, 04/2/23 - 04:27 pm
Bristol Myers Squibb
SpaceX
CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
Sun, 04/2/23 - 04:17 pm
EMA
Europe
CHMP
Wegovy
Novo Nordisk
Bimervax
TG Therapeutics
Eli Lilly
Bristol Myers Squibb
Novartis
AstraZeneca
Positive topline data for Bolt’s BDC-1001 in HER2 solid tumours
Clinical Trials Arena
Fri, 03/31/23 - 10:22 am
Bolt Biotherapeutics
BDC-1001
solid tumors
Roche
Bristol Myers Squibb
Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026
Fierce Pharma
Thu, 03/30/23 - 10:59 am
Pfizer
Bristol Myers Squibb
Eliquis
drug pricing
Inflation Reduction Act
CMS
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?
Motley Fool
Tue, 03/28/23 - 10:46 pm
clinical trials
Bristol Myers Squibb
JNJ
milvexian
stroke
BMS re-ups 'highly productive' legacy neurodegeneration partnership with Evotec for $50M upfront
Fierce Biotech
Tue, 03/28/23 - 10:44 pm
Bristol Myers Squibb
Celgene
Evotec
neurodegenerative disease
Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
R&D
Roche
JNJ
Merck
Pfizer
Novartis
AstraZeneca
Bristol Myers Squibb
Eli Lilly
Sanofi
AbbVie
Takeda, chasing Bristol Myers, unveils awaited TYK2 drug data
BioPharma Dive
Sun, 03/19/23 - 01:46 pm
Takeda
Bristol Myers Squibb
clinical trials
TAK-279
plaque psoriasis
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
CP WIre
Sat, 03/18/23 - 03:37 pm
Medtronic
Medtech
inflation
drug pricing
Pfizer
Novartis
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Yervoy
lung cancer
Xiidra
JNJ
executive compensation
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Sat, 03/18/23 - 03:35 pm
Medtronic
Medtech
inflation
drug pricing
Pfizer
Novartis
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Yervoy
lung cancer
Xiidra
JNJ
executive compensation
Bristol Myers meets some diversity goals early, while missing others
Endpoints
Wed, 03/15/23 - 09:28 pm
Bristol Myers Squibb
diversity
clinical trials
clinical trial diversity
Bristol Myers blasts off with SpaceX to study biomanufacturing in space
Endpoints
Wed, 03/15/23 - 09:18 pm
Bristol Myers Squibb
SpaceX
Exscientia builds cancer pipeline with two BMS drugs
Pharmaphorum
Wed, 03/15/23 - 09:57 am
Exscientia
Bristol Myers Squibb
oncology
EXS73565
EXS74539
In PD-1 rivalry, Merck's Keytruda catches up with Opdivo in rare lung cancer type
Fierce Pharma
Fri, 03/10/23 - 11:20 am
Merck
Keytruda
Opdivo
Bristol Myers Squibb
pleural mseothelioma
mesothelioma
clinical trials
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »